HE4 Levels in Ovarian Cancer-Resistant Menopausal Women

Kadar HE4 pada wanita menopause yang resisten kanker ovarium

  • Wiwi Irawan Faculty of Medicine Universitas Hasanuddin Dr. Wahidin Sudirohusodo General Hospital Makassar
  • Syahrul Rauf Faculty of Medicine Universitas Hasanuddin Dr. Wahidin Sudirohusodo General Hospital Makassar
  • Nasrudin A. Mappaware Faculty of Medicine Universitas Hasanuddin Dr. Wahidin Sudirohusodo General Hospital Makassar
  • St. Maisuri T. Chalid Faculty of Medicine Universitas Hasanuddin Dr. Wahidin Sudirohusodo General Hospital Makassar

Abstract

Abstract


Objective: To analyse the predictive value of HE4 in ovarian cancer patients according to their resistance and menopausal status

Methods: Thirteen premenopausal and twenty-five menopausal ovarian cancer patients were measured for HE4 levels measured using automated chemiluminescent microparticle immunoassay ARCHITECT HE4. Patients categorized into resistant and non-resistant after six cycles of chemotherapy in addition to their clinical symptoms and ultrasound image of cancer.

Results: The mean HE4 levels were higher in the resistant group compared with a non-resistant group (274.97 pmol/l vs 128.83 pmol/l; p=0.015). Five menopausal resistant women with HE4 levels >140 pmol/l compared with two women in the non-resistant group. In the pre-menopause group, eight resistant women with HE level >70 pmol/l whereas four women in the non-resistant group. HE levels in menopausal and premenopausal for both ovarian cancers resistant and non-resistant were not significantly different (p>0.05).

Conclusion: HE4 levels in resistant ovarian cancer patients are higher compared with non-resistant but do not predict ovarian cancer resistance based on patient menopausal status.

Keywords: HE4, ovarian cancer, resistance.

 

Abstak

Tujuan: Untuk menganalisis nilai prediktif HE4 pada pasien kanker ovarium berdasarkan resistensi dan status menopausenya

Metode: Dilakukan pengukuran kadar HE4 menggunakan metode microparticle immunoassay ARCHITECT HE4 terhadap pasien kanker ovarium terdiri dari 13 perempuan premenopausal dan 25 perempuan menopause. Pasien dikategorikan menjadi resisten dan tidak resisten setelah 6 siklus kemoterapi selain gejala klinis dan gambar USG.

Hasil: Rerata kadar HE4 rata-rata lebih tinggi pada kelompok yang resisten dibandingkan dengan kelompok yang tidak resisten (274,97 pmol/l vs 128,83 pmol/l; p=0,015). Terdapat 5 perempuan menopause yang resisten kanker ovarium dan 2 perempuan dalam kelompok yang tidak resisten dengan kadar HE4 >140 pmol/l. Pada kelompok premenopause, 8 perempuan yang resisten dengan tingkat HE >70 pmol/l sedangkan 4 perempuan dalam kelompok tidak resisten. Kadar HE dalam menopause dan premenopause untuk kedua kanker ovarium resisten dan tidak resisten tidak berbeda secara signifikan (p>0,05).

Kesimpulan: Kadar HE4 pada pasien kanker ovarium lebih tinggi daripada tidak resisten tetapi tidak memprediksi resistensi kanker ovarium berdasarkan status menopause pasien.

Kata kunci : HE4, kanker ovarium, resistensi .

Downloads

Download data is not yet available.

Author Biographies

Syahrul Rauf, Faculty of Medicine Universitas Hasanuddin Dr. Wahidin Sudirohusodo General Hospital Makassar

Departement of Obstetrics and Gynecology

Nasrudin A. Mappaware, Faculty of Medicine Universitas Hasanuddin Dr. Wahidin Sudirohusodo General Hospital Makassar

Departement of Obstetrics and Gynecology

St. Maisuri T. Chalid, Faculty of Medicine Universitas Hasanuddin Dr. Wahidin Sudirohusodo General Hospital Makassar

Department of Obstetrics and Gynecology

 

Published
2019-07-26
Section
Research Article